Trevena shares were on fire in after hours trading on Tuesday after the biotech company announced that the Food and Drug Administration has accepted for review a new drug application (NDA) of the company’s opioid-replacement painkiller, Olinvo. Shares were up as much as 25% after Wall Street got wind of the enws. The FDA is … Continue reading “Trevena Soars on FDA News Over Opioid Replacement Pain Killer”
